GlassScriptPhysician profile
Emily A Comstock
NPI 1578514758
$1,869.44
in general payments reported to CMS, 2019-2025
16 companies · $628 in 2025
The $628 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $218 · 2023: $483 · 2024: $382 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $766.66 | 2021-2025 | |
| Amgen INC. | $327.45 | 2023-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $184.67 | 2021-2025 | |
| Glaxosmithkline, LLC. | $184.56 | 2021-2024 | Trelegy Ellipta, Arexvy, Bexsero |
| Novo Nordisk INC | $113.15 | 2022-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $77.34 | 2021-2023 | Verquvo, Steglujan, Januvia |
| Astellas Pharma US INC | $60.42 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $37.20 | 2023 | Thinprep 2000 Processor |
| Abbott Laboratories | $20.37 | 2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $15.35 | 2024 | Airsupra |
| Corcept Therapeutics | $14.43 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $14.15 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $14.04 | 2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $13.92 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.95 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Comstock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.